The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries.
epidemiology: RSV
respiratory infections
surveillance
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
17
01
2021
accepted:
25
03
2021
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
3
8
2021
Statut:
epublish
Résumé
Respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infections. To optimize control strategies, a better understanding of the global epidemiology of RSV is critical. To this end, we initiated the Global Epidemiology of RSV in Hospitalized and Community care study (GERi). Focal points from 44 countries were approached to join GERi and share detailed RSV surveillance data. Countries completed a questionnaire on the characteristics of their surveillance system. Fifteen countries provided granular surveillance data and information on their surveillance system. A median (interquartile range) of 1641 (552-2415) RSV cases per season were reported from 2000 and 2020. The majority (55%) of RSV cases occurred in the <1-year-olds, with 8% of cases reported in those aged ≥65 years. Hospitalized cases were younger than those in community care. We found no age difference between RSV subtypes and no clear pattern of dominant subtypes. The high number of cases in the <1-year-olds indicates a need to focus prevention efforts in this group. The minimal differences between RSV subtypes and their co-circulation implies that prevention needs to target both subtypes. Importantly, there appears to be a lack of RSV surveillance data in the elderly.
Sections du résumé
BACKGROUND
BACKGROUND
Respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infections. To optimize control strategies, a better understanding of the global epidemiology of RSV is critical. To this end, we initiated the Global Epidemiology of RSV in Hospitalized and Community care study (GERi).
METHODS
METHODS
Focal points from 44 countries were approached to join GERi and share detailed RSV surveillance data. Countries completed a questionnaire on the characteristics of their surveillance system.
RESULTS
RESULTS
Fifteen countries provided granular surveillance data and information on their surveillance system. A median (interquartile range) of 1641 (552-2415) RSV cases per season were reported from 2000 and 2020. The majority (55%) of RSV cases occurred in the <1-year-olds, with 8% of cases reported in those aged ≥65 years. Hospitalized cases were younger than those in community care. We found no age difference between RSV subtypes and no clear pattern of dominant subtypes.
CONCLUSIONS
CONCLUSIONS
The high number of cases in the <1-year-olds indicates a need to focus prevention efforts in this group. The minimal differences between RSV subtypes and their co-circulation implies that prevention needs to target both subtypes. Importantly, there appears to be a lack of RSV surveillance data in the elderly.
Identifiants
pubmed: 34337092
doi: 10.1093/ofid/ofab159
pii: ofab159
pmc: PMC8320297
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofab159Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
J Infect. 2007 Jun;54(6):530-8
pubmed: 17097147
PLoS One. 2017 Nov 30;12(11):e0186735
pubmed: 29190684
BMC Infect Dis. 2010 Jun 09;10:162
pubmed: 20534113
BMC Infect Dis. 2015 Oct 23;15:443
pubmed: 26497750
Br J Psychiatry. 2019 Apr 12;:1
pubmed: 30975245
BMC Public Health. 2017 Mar 21;17(1):271
pubmed: 28320361
Respir Med. 2004 Sep;98(9):879-82
pubmed: 15338801
PLoS One. 2017 Aug 10;12(8):e0182321
pubmed: 28797053
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Influenza Other Respir Viruses. 2020 Nov;14(6):647-657
pubmed: 31670892
Lancet Glob Health. 2019 Aug;7(8):e1031-e1045
pubmed: 31303294
Influenza Other Respir Viruses. 2020 Nov;14(6):638-646
pubmed: 32163226
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
Infect Dis Ther. 2016 Sep;5(3):271-98
pubmed: 27480325
Clin Infect Dis. 2009 Nov 1;49(9):1341-9
pubmed: 19788358
J Glob Health. 2015 Dec;5(2):020101
pubmed: 26755941
Epidemiol Infect. 2020 Feb 13;148:e48
pubmed: 32052719
J Infect Dis. 2013 Dec 15;208 Suppl 3:S238-45
pubmed: 24265483
Influenza Other Respir Viruses. 2019 Mar;13(2):138-147
pubmed: 30596225
Clin Infect Dis. 2012 May;54(10):1427-36
pubmed: 22495079
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Influenza Other Respir Viruses. 2018 Jan;12(1):113-121
pubmed: 29243369
J Infect Dis. 2020 Oct 7;222(Suppl 7):S577-S583
pubmed: 30880339
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184